Pathology Test Details

Item Details
Laboratory Canterbury District Health Board : Canterbury Health Laboratories - CHRISTCHURCH
Test Name ABL1 tyrosine kinase domain mutation analysis
Genes Tested BCR/ABL1
Test Description Detection of nucleotide substitutions in the tyrosine kinase domain of ABL1 of BCR-ABL1 fusion gene.
Method Sanger sequencing
Test Type Single
Comment Requested for BCR-ABL1 positive patients with a sub-optimal response to TKI treatment.
Test Accreditation Not In NATA Scope
Clinical Context Somatic mutation
Sample Required 10 ml EDTA blood or 2-5 ml bone marrow aspirate in EDTA.
Turn Around Time 3-4 weeks
Medicare Rebate No Medicare rebate
Pathology Test Last Edit Date 3/07/2017 10:22:24 AM
03-Jul-2017
Go Back
Site Statistics
No. of genes : 3454
No. of labs : 37
No. of tests : 5345

Page last updated:

Copyright © 2020 RCPA. All rights reserved.

25-Jan-2019
Top